S&P・Nasdaq 本質的価値 お問い合わせ

111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
$32.89
+383%

111, Inc. (YI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $3.57 および 売上高 $2.12B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-7.52 vs 予想 $3.57 (下回る -310.8%). アナリスト精度: 0%.

EPS予測 — YI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$7.52 vs Est $3.57 ▼ 147.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

売上高予測 — YI

15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $14.401B vs Est $2.122B ▲ 85.3% off
Revenue Trend
Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る